Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer
about
Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypesIdentifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataGenomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survivalMAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosisRadiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell linesA role for tumor protein TPD52 phosphorylation in endo-membrane trafficking during cytokinesisGene expression differences predict treatment outcome of merkel cell carcinoma patientsOverexpressed oncogenic tumor-self antigensThe use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.Role of annexin A6 in cancer.Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinomaInjection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage.DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer riskmiR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52.BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications.The testicular germ cell tumour transcriptome.All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.Genomic copy number and expression patterns in testicular germ cell tumours.Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of ChondrocytesTumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.Androgen-dependent alternative mRNA isoform expression in prostate cancer cells
P2860
Q27333989-20A53983-0D30-4B71-BC47-B99784C8F225Q30587051-34E09C18-F8E4-487A-B827-7F89D4F57CEEQ33239655-3201F624-A58A-4D41-BE97-A8C2A3556BA2Q33406769-65E05559-AB9D-48CC-B991-FF66F761D17DQ33694015-7B779242-32B0-494F-90CB-D951DA242DE1Q33745941-D447D417-C503-4D5D-B4A2-5E09CEF1E109Q34239148-B9F58065-C07D-4C0D-BF72-75C051F424C3Q34517584-11936DCE-7153-41B0-ABDE-32C5E07EF169Q35122235-0215E2C5-5ACB-41BF-B8BB-D663114AF2A8Q35886756-F899300D-2DEC-4AEA-A9D9-58FA5713E3DCQ35891644-BA3E88CD-BC80-4F2F-87FC-8AD4075A495EQ36085446-C9E75E50-805B-4576-8D2B-6CA9C31A88D3Q36905913-84096C2B-4EF0-4974-86C5-3212E43C1D45Q37195269-5AB21AE0-3171-4395-A3F2-BADB772B0D8EQ37219890-7212752C-E9D7-4829-BDFB-7E09918A5501Q37308114-7A044340-54BE-47E6-A0C7-1D391603AECEQ37344530-C59D37D4-4ADD-42FC-9142-9D700490826DQ37770590-ECB37C57-7A23-4E83-8D2B-C102CFF2B9D7Q37886262-FF61DBFF-9C7B-451C-9404-DD56FF89F6B4Q38823738-DDA39150-3091-4658-9C1D-184CA24A7F6EQ38880242-25CE354A-BD6A-48A5-9BB5-469F287AA30DQ39384713-37FBB56A-373E-4972-875A-22C56A1B38CAQ39923830-740FF443-5E4A-4ED6-9137-100C3DB53B1BQ40039629-559F682F-9634-4A0F-8F1E-5FEB93617AEBQ41180083-FD8634D8-64B5-46D7-B361-73E3B2DC8855Q51022990-0BC943D1-C4E1-4310-9395-EA6B183749B1Q54441612-A168648C-4E9E-42BB-8A3D-C93E72A8F376Q57135534-169897BC-E3E6-47DB-8D13-99A241562D84
P2860
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@ast
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@en
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@nl
type
label
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@ast
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@en
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@nl
prefLabel
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@ast
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@en
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@nl
P2093
P2860
P50
P3181
P356
P1476
Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer
@en
P2093
Beth Y Karlan
Dennis J Slamon
Gregory B Peters
Janelle Mercieca
Karen Byth
Luke St Heaps
Marlena Schoenberg Fejzo
Rosemary L Balleine
Yael Livnat
Yoke-Eng Chiew
P2860
P304
P3181
P356
10.1002/IJC.21250
P407
P577
2005-12-20T00:00:00Z